1.
David Oscier, Rachel Wade, Zadie Davis, Alison Morilla, Giles Best, Sue Richards, Monica Else, Estella Matutes, Daniel Catovsky. Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. haematol [Internet]. 2010Oct.1 [cited 2022May28];95(10):1705-12. Available from: https://haematologica.org/article/view/5755